FDA Grants Insulin Lispro-aabc Label Expansion for use in Insulin Pumps
August 21, 2021

The novel prandial insulin formulation from Eli Lilly is now approved for administration via continuous subcutaneous insulin infusion with an insulin pump.

Hyperglycemia in Hospitalized COVID-19 Patients Linked with Worse Outcomes
March 22, 2021

COVID-19 patients with hyperglycemia on hospital admission, with and without diabetes, had increased odds of intubation, ICU admission, and mortality, according to research presented at ENDO 2021.

Novel Once-weekly Insulin as Effective as Once-daily in Type 2 Diabetes with Less Hypoglycemia, Weight Gain
March 21, 2021

ENDO 2021: An investigational once-weekly insulin formulation was found as effective as daily basal insulin injection for glucose control with lower rates of hypoglycemia and less weight gain.

Diana Isaacs, PharmD: An Overview of Insulin Affordability in 2020
September 01, 2020

Insulin affordability is an ongoing discussion topic for patients with diabetes and their care providers. The already difficult issue has been further compounded by the ongoing COVID-19 pandemic.

Issues in Insulin Management: 3 Cases of Type 2 Diabetes
June 24, 2020

Three patients with type 2 diabetes in different stages of life and disease all require insulin management for A1c control.

ADA 2017: Insulins go Head-to-Head
June 12, 2017

Insulin degludec vs glargine--which costs less per anum and why? We summarize this study and 2 other direct insulin comparisons reported at ADA 2017.

Primary Care Docs Prefer Tight Glucose Control in T2D
November 05, 2015

Stringent control was supported even in patients at high risk for related harm. Reasons found for concern over Rx "deintensification" may surprise you.

Batting Averages and Sex Improvement
March 26, 2015

Here’s a look at what’s new and interesting on the Web for health care professionals.

Diabetes Control Too Tight for Some Older Adults
January 15, 2015

Maintaining tight glycemic control in older diabetic adults who are in poor health can do far more harm than good, according to results of a new study.

Opioid Receptors May Curb Hypoglycemia in Diabetes
June 17, 2014

Activation of opioid receptors with novel approaches may prevent hypoglycemia and lead to safer intensive glycemic control, according to a study reported at the American Diabetes Association 74th Scientific Sessions.